Mastering Postprandial Glucose Control – Strategies for Optimal Diabetes Management

Join us for an enlightening webinar titled “Mastering Postprandial Glucose Control: Strategies for Optimal Diabetes Management,” supported by Mannkind. This session will equip healthcare professionals with a deeper understanding of postprandial glucose excursions and their significance in diabetes management. Our expert speakers will cover both pharmacological approaches and lifestyle interventions, providing actionable strategies to enhance postprandial glucose control.

Date: 2 July 2024
Time: 16:00 CET (Find your timezone)

REGISTER

Learning Objectives

  • Understand the role of postprandial glucose control in diabetes management:
  • Gain insights into the latest pharmacological treatments for managing postprandial glucose.
  • Understand the mechanisms and efficacy of different medications in controlling post-meal blood glucose spikes.
  • Learn about effective lifestyle modifications to aid in postprandial glucose management.
  • Understand the roles of diet, physical activity, and other behavioral changes in optimizing glucose levels.

Agenda

  • Welcome & Introductions (10 min)
  • Understanding Postprandial Glucose Excursion (overview, importance in diabetes management, and influencing factors) (15 min) by Dr. Andrew Welch
  • Pharmacological Approaches & Lifestyle Interventions for Postprandial Glucose Control (15 min) by Dr. Halis Akturk
  • Q&A session (15 min)
  • Closing & Final Remarks (5 min)

Faculty

Andrew Welch(1)
Andrew Welch, BS, DO, UC Medical Center

Andrew Welch, DO, is a compassionate and dedicated endocrinologist who believes in a patient-centered approach to care. Inspired by the words of William J. Mayo, “The needs of the patient come first,” Dr. Welch envisions a world where people with diabetes can live normal lives, free from the burdens of constant monitoring and treatment. As an individual living with type 1 diabetes himself, he has a unique understanding of the challenges faced by his patients and is highly motivated to find innovative solutions.

Halis Kaan Akturk
Halis Kaan Akturk, Associate Professor of Medicine and Pediatrics·Barbara Davis Center for Diabetes, University of Colorado

Dr. Akturk is an Associate Professor of Medicine and Pediatrics at the Barbara Davis Center for Diabetes, University of Colorado. His research is focused on improving glycemic control with advanced diabetes technologies and therapeutics in people with type 1 diabetes. He has been the PI in many clinical trials assessing diabetes technologies and therapeutics such as hybrid closed loop pumps and continuous glucose monitors. He has been a part of the main clinical studies of Medtronic 780G HCL, Dexcom G7 CGM, Eversense E3 CGM, insulin lispro-aabc, inhaled insulin and adjunctive therapies in development such as glucagon receptor antagonists.

This activity is supported by Mannkind.